Reversible cardiomyopathy due to secondary hemochromatosis with multitransfusions for severe aplastic anemia after successful non-myeloablative stem cell transplantation

MLA

S. Nakao, et al. “Reversible Cardiomyopathy Due to Secondary Hemochromatosis with Multitransfusions for Severe Aplastic Anemia after Successful Non-Myeloablative Stem Cell Transplantation.” International Journal of Cardiology, vol. 127, July 2008, pp. 400–01. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........f8314901c5fa49460ff1e797b24f790f&authtype=sso&custid=ns315887.

APA

S. Nakao, Norihiro Sato, Takao Koike, Mitsufumi Nishio, & Tomoyuki Endo. (2008). Reversible cardiomyopathy due to secondary hemochromatosis with multitransfusions for severe aplastic anemia after successful non-myeloablative stem cell transplantation. International Journal of Cardiology, 127, 400–401.

Chicago

S. Nakao, Norihiro Sato, Takao Koike, Mitsufumi Nishio, and Tomoyuki Endo. 2008. “Reversible Cardiomyopathy Due to Secondary Hemochromatosis with Multitransfusions for Severe Aplastic Anemia after Successful Non-Myeloablative Stem Cell Transplantation.” International Journal of Cardiology 127 (July): 400–401. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........f8314901c5fa49460ff1e797b24f790f&authtype=sso&custid=ns315887.